NTF4 and pancreatic adenocarcinoma: Importantly, NT4 inhibited oriented migration of pancreas adenocarcinoma cells (13) as well as growth factor-induced migration and invasiveness of breast cancer cells, implying antagonist binding to HSPG (13, 20).